News Releases

ASOP Global Encouraged by Inclusion of Consumer Health and Safety Protections in America COMPETES Act

January 28, 2022

The Alliance for Safe Online Pharmacies (ASOP Global) is encouraged to see the inclusion of critical consumer health and safety protections in the America Competes in Manufacturing, Pre-Eminence in Technology, and Economic Strength Act (America COMPETES Act) introduced in the House this week.

ASOP Global Applauds Senate Commerce Subcommittee for Highlighting the Dangers of Online Counterfeit Drugs

October 26, 2021

The Alliance for Safe Online Pharmacies (ASOP Global) applauds the Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Data Security for calling attention to the dangers of deadly drugs easily obtained online.

ASOP Global Urges Swift Passage of the INFORM Consumers Act

October 14, 2021

ASOP Global applauds Congress for moving the INFORM Consumers Act quickly through the legislative process and urges the bill’s swift passage to send a powerful message to online criminals that they can no longer act anonymously and without punishment.

ASOP Global Statement on SHOP SAFE Markup

September 29, 2021

The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement regarding the SHOP SAFE Act of 2021 markup.

ASOP Global Condemns Websites Falsely Marketing Ivermectin as a COVID Cure

September 15, 2021

ASOP Global joins members of the American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP), along with the American Medical Association (AMA), in warning against the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.

ASOP Global Participates in Third FDA Online Opioid Summit

September 9, 2021

The Alliance for Safe Online Pharmacies (ASOP Global) will participate in the third U.S. Food and Drug Administration (FDA) Online Opioid Summit. The Summit provides a critical forum for experts from academia, government, private, and nonprofit sectors to collaborate on ways to detect and reduce the availability of opioids on the internet.

ASOP EU and Health Stakeholders Call on European Parliament, European Council to Expand Digital Services Act to Include Internet Intermediaries

July 18, 2021

The Alliance for Safe Online Pharmacies in the EU (ASOP EU), along with six health-centered organizations, co-signed a letter to members of the European Parliament and the European Council requesting the expansion of the proposed Digital Services Act (DSA) to include online intermediaries.

New National ASOP Foundation Survey:  As More Americans Buy Meds on the Internet, Most Prioritize Cost & Convenience Over Safety.

July 12, 2021

According to a new national survey the ASOP Global Foundation commissioned from Abacus Data, nearly half of American consumers are willing to risk threats to their health by purchasing medications from unregulated online sources for the sake of more convenience and lower prices. Further, U.S drug importation policies give consumers a false sense of security, leading many to misbelieve that all Canadian medicines sold online are safe and legitimate. Alarmingly, more than one-third of consumers polled say they would knowingly ignore explicit government prohibitions from buying medicines from Canadian online pharmacies because of their misperceptions that they can safely access cheaper medications from sources abroad.

ASOP Global Opposes New Biden Policy on Canadian Drug Importation. 

July 12, 2021

Friday, President Biden issued an Executive Order that directs the Food and Drug Administration (FDA) to work with states and tribes on plans to import prescription drugs from Canada. In response, Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.

ASOP Global Applauds HHS Reversal of the Trump Administration’s Drug Importation Scheme

 July 8, 2021

The Alliance for Safe Online Pharmacies issued the following statement in response to the Department of Health and Human Services announcement that it will revoke a Trump-era call for proposals to create pathways for personal prescription drug and insulin importation from other countries.

ASOP EU Gains Official Observer Status at the Medicrime Convention Committee of the Parties

May 26, 2021

The Alliance for Safe Online Pharmacy in the EU (ASOP EU) has joined the Medicrime Committee of the Parties (CoP) as an Observer.

ASOP Global Expresses Support for SHOP SAFE Act

May 26, 2021

The Alliance for Safe Online Pharmacies issued the following statement in support of the “Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce Act” (SHOP SAFE Act) and this week’s congressional hearing on the legislation.

ASOP Global Endorses INFORM Consumers Act

May 25, 2021

the Alliance for Safe Online Pharmacies issued the following statement in support of the bipartisan Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act (INFORM Consumers Act).

New Report Demonstrates Implementing the Falsified Medicines Directive in Hospitals Brings Massive Positive Change

April 7, 2021

The European Alliance for Access to Safe Medicines (EAASM) has published its report ‘Patient Safety and the Implementation of the Falsified Medicines Directive in the Hospital Environment: Practical solutions and benefits’. Read the full release here.

ASOP Global Statement on Congressional Hearing with CEOs of Facebook, Twitter, and Google
March 26, 2021

The Alliance for Safe Online Pharmacies issued the following statement about yesterday’s joint hearing on disinformation and the role of social media before the Subcommittee on Communications and Technology and the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce.

ASOP Global Welcomes Opportunity to Work with HHS Secretary Becerra

March 18, 2021

Today, the Alliance for Safe Online Pharmacies issued the following statement in response to the United States Senate’s confirmation of Department of Health and Human Services Secretary Xavier Becerra.

ASOP Global Applauds the Reintroduction of the PACT Act
March 17, 2021

The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in support of the recently reintroduced Platform Accountability and Consumer Transparency Act (PACT Act).

Novartis Joins ASOP Global as Newest Member
February 2, 2021
The Alliance for Safe Online Pharmacies is proud to welcome global health care company Novartis as a new member organization.

ASOP Global Reaffirms Support for Targeted Section 230 Reform Bill
February 1, 2021

The Alliance for Safe Online Pharmacies issued the following statement in response to the reintroduction of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).

ASOP Global Applauds NTIA for Urging Congress to Protect Americans Online
January 6, 2021
As a member of the Coalition for a Secure and Transparent Internet (CSTI), the Alliance for Safe Online Pharmacies (ASOP Global) signed recent letters applauding the National Telecommunications and Information Administration (NTIA) for calling on the House and Senate to address open access to accurate WHOIS data.

ASOP Global Commends U.S. Attorney Hur for Fighting Against COVID-19 Fraud
December 21, 2020
In response to the recent seizure by the U.S. Attorney’s Office for the District of Maryland of websites for fraudulently posing as legitimate biotechnology companies actively developing treatments for COVID-19, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.

ASOP Global Urges Consumers to Remain Aware of COVID-19 Fraud
December 11, 2020
In response to the anticipated emergency use authorizations (EUAs) for several COVID-19 vaccines and availability of a direct-to-consumer COVID-19 test system, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.

ASOP Canada Statement on Health Canada Interim Order to Prevent Diversion of Canada’s Drug Supply
November 30, 2020
In response to Health Canada’s release of an Interim Order (IO) to prevent the diversion of Health Canada-approved medicines, ASOP Canada issued the following statement.

ASOP Global Statement of Opposition to Drug Importation Rule
November 30, 2020
In response to the U.S. Food and Drug Administration’s (FDA) Importation of Prescription Drugs Final Rule taking effect today, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement of opposition.

ASOP Global Statement On Launch Of Amazon Pharmacy
November 17, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the launch today of Amazon Pharmacy.

New Survey Reveals Dangerous Disconnect in American Perceptions of Online Pharmacies
October 19, 2020
According to a new national survey the Alliance for Safe Online Pharmacies (ASOP Global) commissioned from Abacus Data, the COVID-19 pandemic is accelerating an already growing trend toward the digitalization of the healthcare industry, including increased utilization of telemedicine and the purchase of medications online.

ASOP Global Statement on New Section 230 Reform Bill 
September 29, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the introduction today of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).

ASOP Global Statement on the Publication of FDA’s Final Rule on Drug Importation
September 25, 2020
In response to yesterday’s publication of the U.S. Food and Drug Administration’s (FDA) Final Rule on Drug Importation, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.

ASOP Canada Statement on U.S. Final Rule to Import Prescription Medicines from Canada
September 25, 2020
In response to yesterday’s announcement by the Trump Administration and final regulations to allow importation of prescription medicines, ASOP Canada issued the following statement.

ASOP Global Statement on FDA Crackdown on Website Operators Illegally Selling Opioids
September 10, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to warning letters issued by the U.S. Food and Drug Administration to 17 website operators advertising and selling illegal, unapproved and misbranded opioids online.

ASOP Global Statement on President Trump’s Executive Order on Accelerated Timeline for State Drug Importation Proposals
July 27, 2020
In response to the Executive Order President Trump signed Friday to set price controls on drugs imported from other countries into the U.S., the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement.

ASOP Global Applauds the Introduction of the Platform Accountability and Consumer Transparency Act
June 24, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to today’s announcement by Senate Commerce, Science, Transportation Subcommittee on Communications, Technology, Innovation and the Internet Chairman John Thune (R-SD) and Ranking Member Brian Schatz (D-HI) regarding the introduction of the Platform Accountability and Consumer Transparency Act (PACT Act).

Canadians are more open to ordering medication and medical supplies online amid the COVID-19 pandemic
June 18, 2020
A new comprehensive survey released today from the Alliance for Safe Online Pharmacies Canada (ASOP Canada) revealed that since the COVID-19 pandemic began, half of Canadians have become more open to ordering medication, medical supplies or other healthcare products online.

Youth IGF Movement Form An Alliance With 3 French Healthcare Companies And ASOP EU Launching A Global Education Programme To Combat COVID-19 Scams And Fake Medicines
June 10, 2020
The Youth IGF Movement, created by Yuliya Morenets, has teamed up with the Alliance for Safe Online Pharmacy in the EU (ASOP EU) supported by three French global healthcare companies Ipsen, Sanofi and Servier to educate the youth about buying fake medicines online in particular COVID-19 scams. The campaign is called “We rely on you. We rely on youth”.

ASOP Global Statement on FDA/NTIA Pilot Program to Stop Illegal Online Opioid Sales
June 9, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to yesterday’s joint announcement by the U.S. Food and Drug Administration (FDA) and the National Telecommunications and Information Administration (NTIA) of a new pilot program to help stop the illegal sale of opioids online.

ASOP Global Commends USTR for Identifying Bad Actors in Domain Name Industry
May 5, 2020
In response to the release of the Office of the United States Trade Representative’s (USTR) annual Special 301 Report on Intellectual Property Protection and Review of Notorious Markets for Counterfeiting and Piracy, ASOP Global issued the following statement.

43 Stakeholders Have Now Joined ASOP Global’s Call for the Administration to Take Action to Protect Consumers from Online COVID-19 Scams and Misinformation
April 21, 2020
More than 40 public health, trade association, industry, and research groups, including the National Consumers League (NCL) and the Coalition for a Secure and Transparent Internet (CSTI), have now joined the Alliance for Safe Online Pharmacies (ASOP Global) in urging Vice President Mike Pence, members of the White House Coronavirus Task Force, cabinet officials, and other state and national leaders to take further action to protect consumers from online COVID-19 scams and misinformation.

ASOP Global Statement on Senators’ Call for Domain Industry Accountability to Combat COVID-19 Misinformation and Fraud
April 15, 2020

In response to letters sent by Senators Mazie Hirono (D-Hawaii), Cory Booker (D-N.J.) and Maggie Hassan (D-N.H.) calling on domain name registrars and hosts to fight scams and misinformation during the COVID-19 crisis, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement today.

ASOP Global Urges Administration to Act Now to Protect Consumers from Online COVID-19 Scams and Misinformation
April 9, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) and more than 30 other public health, trade association, industry, and research groups, including the National Consumers League (NCL) and the Coalition for a Secure and Transparent Internet (CSTI), sent a joint letter today to Vice President Mike Pence, members of the White House Coronavirus Task Force, cabinet officials, and other state and national leaders urging them to take further action to protect consumers from online COVID-19 scams and misinformation.

In response to the newly released report by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) entitled “Illicit Trade in Counterfeit Pharmaceutical Products,” the Alliance for Safe Online Pharmacy in the EU (ASOP EU) applauds the research conducted to better highlight and quantify the pervasive threat of illegal online drug sellers.

ASOP Global Statement on EUIPO and OECD Counterfeit Pharmaceuticals Trade Report
March 23, 2020
In response to a new report released by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) on fake medicines and the global illicit trade in counterfeit pharmaceuticals, the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement

ASOP Global Statement on Fake COVID-19 Claims Online
March 20, 2020

In response to widespread misinformation about COVID-19 online, the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement today.

ASOP Global Names ASHP’s Schulte Wall to Board of Directors
March 5, 2020

The Alliance for Safe Online Pharmacies (ASOP Global) has named Jillanne Schulte Wall, J.D. to its board of directors.

ASOP Global Names New Board of Director Members
January 24, 2020
ASOP Global has named three new members to its board of directors, including former U.S. Food and Drug Administration compliance and policy official Dr. Ilisa Bernstein.

ASOP Canada Statement on Proposed Regulations to Import Prescription Medicines from Canada
December 18, 2019
In response to today’s announcement by announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines, ASOP Canada issued the following statement.

ASOP Global Statement On HHS Drug Importation Announcement
December 18, 2019
In response to today’s announcement by Health and Human Services Secretary Alex Azar on the White House’s plan to allow U.S. consumers to import drugs from Canada, ASOP Global issued the following statement.

Black Women’s Health Imperative Joins ASOP Global As Newest Member
December 17, 2019
With a shared commitment to justice in health, ASOP Global is pleased to welcome BWHI as its newest member.

ASOP Canada and 14 Canadian Health Stakeholders Urge Prime Minister Trudeau, Health Canada to Protect Canadian Patients as U.S. Drug Importation Plans Accelerate
November 7, 2019
ASOP Canada and 14 Canadian organizations issued a letter to Prime Minister Justin Trudeau to express serious concern regarding U.S. drug importation plans

ASOP Global Statement on FDA/DEA Online Opioid Efforts
September 30, 2019
ASOP Global issued the following statement in response to the joint warning letters sent by the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration to online networks selling opioids.

ASOP Global Honors Rep. McKinley with Annual Patient Safety Champion Award
September 12, 2019

ASOP Global honored Rep. David McKinley (R-WV) with the organization’s annual ASOP Global Patient Safety Champion Award for his commitment to combatting the opioid epidemic and drug addiction.

Release of ASOP Global and LegitScript “The Chinese Internet Pharmacy Market Threat Assessment” Report
August 15, 2019
ASOP Global and LegitScript are pleased to release a new report titled “The Chinese Internet Pharmacy Market Threat Assessment.” ASOP Global contracted with LegitScript to prepare this study as part of the ASOP Global China Initiative, beginning in 2015.

ASOP GLOBAL Statement on HHS Drug Importation Announcement
July 31, 2019
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to today’s announcement by Health and Human Services Secretary Alex Azar on the White House’s plan to allow U.S. consumers to import drugs from Canada.

ASOP Canada Urges Health Canada to Protect Canadian Drug Supply in Wake of U.S. Drug Importation Legislation, Along With 14 Other Canadian Health Stakeholders
July 26, 2019
ASOP Canada issued a letter to Canada’s Minister of Health Ginette Petitpas Taylor to express concern about U.S. state and federal legislation that permits the importation of Health Canada-approved medicines to the United States.

ASOP Global, Partnership for Safe Medicines: 300,000 Child Fatalities Annually Due To Counterfeit Medication
June 17, 2019
A peer-reviewed article in the American Journal of Tropical Medicine and Hygiene identifies the economic and human impact of counterfeit medicines. ASOP Global and PSM created a new infographic to help explain the deadly impact counterfeit medicines have, where they come from, and how they contribute to microbial resistance.

ASOP EU & Youth IGF Join Forces To Educate Youth Around the World of Fake Medicines Being Sold on the Internet
June 3, 2019
Buying medicines from unsafe sources can be dangerous and perhaps even deadly. More and more people turn to the Internet for goods and services, and medicines are not an exception to this growing trend.

ASOP Global Praises New USTR Notorious Markets Report
April 25, 2019
Patient safety advocates pleased that report recognizes pervasive threat posed by illegal online drug sellers and calls out bad actors.

ASOP Global Applauds FDA’s Commitment To Combating Illegal Online Drug Sales
April 5, 2019
The internet is awash with illegal prescription drug sellers claiming to be selling safe FDA- or Health Canada-approved medicines. For most consumers, finding a safe online pharmacy website can be like finding a needle in a haystack.

ASOP Global’s Statement on Congress’ proposed Affordable and Safe Prescription Drug Importation Act and the Safe and Affordable Drugs from Canada Act
January 11, 2019
ASOP Global has significant concerns about the risks of prescription drug importation and the dangers posed by counterfeit medicines.

ASOP Global Honors Sens. Feinstein and Portman for Efforts to Protect Patients Online
November 15, 2018
At a Capitol Hill reception today the nonprofit Alliance for Safe Online Pharmacies (ASOP Global) awarded Sen. Dianne Feinstein (D-CA) and Sen. Rob Portman (R-OH) the organization’s annual ASOP Global Patient Safety Champion Award and STOP Act Champion Award, respectively.

Les Canadiens réclament un règlement sur les pharmacies en ligne
November 14, 2018
Une nouvelle étude révèle les perceptions et les comportements des consommateurs canadiens à l’égard des pharmacies en ligne

Canadians Demand Regulation of Online Pharmacies
November 14, 2018
A new consumer study released today by the Alliance for Safe Online Pharmacies (ASOP Global) found that the majority (64%) of Canadian citizens think they should have the option to purchase their prescription medication online.

ASOP Global Statement on Bing/NABP Pilot Program
November 13, 2018
ASOP Global commends Microsoft’s search engine Bing for partnering with the National Association of the Boards of Pharmacy (NABP).

ASOP Global’s Annual Internet Pharmacy Safety Award Presented to .DK Hostmaster 
October 22, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) presented its annual Internet Pharmacy Safety E-Commerce Leadership Award to .DK Hostmaster at the 2018 ICANN63 today.

ASOP EU-EAASM Autumn 2018 Newsletter
September 25, 2018
A diary of achievements from January to September 2018.

G2 Web Services Joins ASOP Global as New Member
August 7, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) announced today that merchant risk management firm G2 Web Services has joined as a new member dedicated to combatting illegal online drug sellers.

ASOP Canada Statement Regarding Unauthorized EpiPen Sales Through Second-Hand Sellers
August 9, 2018
ASOP Canada is expressing concern following recent reports of the EpiPen auto-injector being sold online through second hand vendor sites.

ASOP Global Statement Welcoming Young People in Recovery as New Member
August 7, 2018
ASOP Global welcomes substance abuse recovery nonprofit Young People in Recovery as a new member organization.

ASOP Global Statement Regarding the Announcement of a Drug Importation Working Group at FDA
July 19, 2018
ASOP Global Statement on announcement of new drug importation working group at FDA.

ASOP Global Statement on FDA Warnings to Websites Marketing Unapproved Opioids
June 5, 2018
Statement on warning letters issued by the FDA to online networks that market unapproved opioids to consumers.

ASOP Global Statement on Largest U.S. Multi-Agency Investigation to Disrupt Sales of Illegal and Counterfeit Pharmaceuticals
May 10, 2018
ASOP Global Statement on law enforcement actions against illegal and counterfeit pharmaceuticals sales in California and Arizona.

Statement on ASOP Global Mission, Members and Funding and Drug Importation Position
May 7, 2018
Statement on ASOP Global Mission, Members and Funding and Drug Importation Position

ASOP Canada Statement on Canada Drugs Case
May 2018
ASOP Canada statement on Canada Drugs case.

ASOP Global CanadaDrugs Statement
May 1, 2018
ASOP Global is pleased that CanadaDrugs case has been settled after years of hard work by U.S. government, federal and state law enforcement and prosecutors to get justice for American patients and their families.

ASOP Global Statement on Congressional Hearings with Facebook CEO Mark Zuckerberg
April 12, 2018
ASOP Global statement regarding Facebook hearing testimony

Alliance for Safe Online Pharmacies Launches ASOP Canada to Protect Canadians from Unsafe Medicine
April 5, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) has launched a local chapter in Canada to better protect Canadians from the illegal online sale of medical products

Fake Medicines Continue to Threaten Consumers – EU Member States Have an Obligation to Act
February 21, 2018
ASOP EU Releases a Progress Report on Public Awareness Campaigns by Country.

ASOP Global Commends the USTR for their 2017 Notorious Markets List
January 16, 2018
ASOP Global statement in response to The Office of the United States Trade Representative (USTR) 2017 Notorious Markets List.

ASOP GLOBAL Statement in Response to Guilty Pleas in CanadaDrugs.com Case
December 18, 2017
ASOP GLOBAL statement in response to guilty pleas in CanadaDrugs.com case.

New Peer-Reviewed Study Finds Online Pharmacies Are Using Twitter To Illegally Sell Fentanyl, Percocet®, Vicodin® and Other Addictive Opiods To U.S. Consumers
October 25, 2017
Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell Percocet®, Vicodin®, Oxycontin®, hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, in direct violation of U.S. federal law.

Alliance for Safe Online Pharmacies (ASOP Global) Announces 2017 Global Patient Safety Champions
October 16, 2017
The Honorable Michael C. Burgess, MD (R-TX-26), Honorable Eugene Green (D-TX-29) and the National Association of Boards of Pharmacy (NABP) have been named the 2017 Global Patient Safety Champions by the Alliance for Safe Online Pharmacies (ASOP Global), it was announced today.

Alliance for Safe Online Pharmacies Applauds Results of Operation Pangea X; Urges Continued Vigilance Against Illegal Online Pharmacies Worldwide
September 28, 2017
The Alliance for Safe Online Pharmacies (ASOP Global) applauded the results of INTERPOL’s Operation Pangea X, the most successful action of its kind to target illegal online pharmacies, but said more must be done to stop the global influx of counterfeit or substandard prescription medicines.

Alliance for Safe Online Pharmacies (ASOP Global) Announces Four New Members
September 22, 2017
Gilead Sciences, Inc., the National Alliance on Mental Illness (NAMI), National Council for Behavioral Health (NCBH), and RESOLVE: The National Infertility Association have joined the Alliance for Safe Online Pharmacies (ASOP Global), it was announced today.

New Survey Reveals Majority of Consumers Are Unaware of Risks Associated With Online Pharmacies, Oppose Legalizing Prescription Drug Importation
July 19, 2017
Results from the most comprehensive survey of 500 U.S. residents to evaluate consumer behavior and perceptions about online pharmacies were released today by the Alliance for Safe Online Pharmacies (ASOP Global).

ASOP Global and ASOP EU Host Best Practice Sharing Workshop
July 11, 2017
The Alliance for Safe Online Pharmacies (ASOP Global) and Alliance for Safe Online Pharmacy (ASOP EU) hosted the fifth Best Practice Sharing Workshop in Paris, France on June 29, 2017.

Libby Baney, partner at Faegre Baker Daniels Consulting and senior advisor to ASOP Global, ASOP EU’s Executive Director, Mike Isles and Klaus Gritschneder were joined by representatives from 20 EU Member States and not-for-profit patient safety organizations from the U.S. and Europe, including the National Association of Boards of Pharmacy (NABP).

GoodRx Joins The Alliance for Safe Online Pharmacies
June 16, 2017
GoodRx, which has saved Americans $3 billion on their prescription medicines since 2011, has joined the Alliance for Safe Online Pharmacies (ASOP Global).

Up to 45% of Americans struggle with paying for their prescription medicines, 26% don’t fill prescriptions because they can’t afford them, and medication nonadherence costs the U.S. healthcare system up to $289 billion a year.

ASOP Global/NABP Canadian Internet Sales Roundtable
May 20, 2017
Libby Baney, partner at Faegre Baker Daniels Consulting and senior advisor to ASOP Global, and NABP’s Policy and Communications Director, Melissa Madigan and Ronald F.Guse, an NABP .pharmacy Canadian consultant, member of the board of the Canadian Patient Safety Institute and former Manitoba Provincial Regulator were the speakers at the first Canadian Internet Drug Sales Roundtable, which was held during NABP’s 113th annual conference in Orlando, FL.

The Security of the Drug Supply Chain, Patient Safety and Drug Importation
April 28, 2017
On Friday, April 28, ASOP Global and The Pew Trusts will hold a briefing on Capitol Hill to discuss the issue of illegal online pharmacies, protections provided by the Drug Supply Chain Security Act, risks associated with undermining those protections, and consequences for patients who are exposed to unsafe products. Open to the public, reporters, members of Congress and their staffs, speakers will include Libby Baney, JD (ASOP Global), Elizabeth Jungman, JD, MPH (Pew),John Hertig, PharmD (Purdue College of Pharmacy), John Horton, JD (LegitScript) and Ali Schroer, LCSW (a patient harmed by drugs she bought from an illegal online pharmacy).

Alliance for Safe Online Pharmacies (ASOP Global) Announces Four New Members
April 6, 2017
The International Alliance for Patients’ Organizations (IAPO), Consumer Online Foundation (COF) India, National Council on Patient Information and Education (NCPIE), and Healthcare Distribution Alliance (HDA) have joined the Alliance for Safe Online Pharmacies (ASOP Global), it was announced today.

Alliance For Safe Online Pharmacies Announces Recipients Of Its First Internet Pharmacy Safety E-Commerce Award
March 21, 2017
The Alliance for Safe Online Pharmacies (ASOP Global) presented its inaugural Internet Pharmacy Safety E-Commerce Leadership Award to Rightside and Realtime Register during the Generic Names Supporting Organization (GNSO) Joint Meeting of the Registries and Registrars Stakeholder Groups at ICANN58 in Copenhagen, Denmark.

ASOP Global and International Partners Host India Forum On Patient Safety and Access to Safe Online Pharmacies
March 1, 2017
The Alliance for Safe Online Pharmacies (ASOP Global), Partnership for Safe Medicines (PSM) India Initiative, International Alliance of Patients’ Organisations (IAPO), Indian Pharmacopeia Commission (IPC), U.S. Pharmacopeial Convention (USP), and leading consumer organizations worked with the Government of India (GoI) to organize and host the March 1-2, 2017 International Forum, “Patient Safety and Access to Safe Online Pharmacies.”

ASOP Global Launches BuySafeRx.pharmacy; Calls on Healthcare Providers to Help Educate Patients
December 15, 2016
The Alliance for Safe Online Pharmacies (ASOP Global) is partnering with the American Medical Association (AMA), American Pharmacists Association (APhA) and 14 other national non-profit organizations.
 View our PR Newswire Multimedia News Release

Visa Inc. Joins ASOP Global
June 16, 2016
Visa Inc. (NYSE: V) is now a member of the Alliance for Safe Online Pharmacies (ASOP Global), it was announced today by Libby Baney, partner at Faegre Baker Daniels Consulting and senior advisor to ASOP Global, and Martin Elliot, global head of brand protection for Visa.

ASOP Global, CSIP and NCL Join Forces to Keep Older Americans Safe Online
June 6, 2016
With an estimated 49.5% growth of the U.S. senior population by 2030 and out-of-pocket prescription drug costs for Medicare beneficiaries skyrocketing.
 View our PR Newswire Multimedia News Release

U.S. Department of Justice to Arraign Fourteen Individuals and Companies for Charges Related to Selling $78 Million Worth of Counterfeit Drugs
August 18, 2016
In a U.S. Department of Justice (DOJ) indictment handed down by a grand jury in November 2014 and unsealed on August 11, 2015.

Counterfeit Medicines, Illegal Online Drug Sellers Targeted in Consumer Education Campaign (#BuySafeRx)
May 14, 2016
With the proliferation of illegal online pharmacies, the Alliance for Safe Online Pharmacies (ASOP Global) has launched “Buy Safe Rx”              
 View our PR Newswire Multimedia News Release

Results of the First Study To Establish A Link Between Twitter and Illegal Online Pharmacies Published In JMIR
December 16, 2015
The results of a new study published today in the Journal of Medical Internet Research (JMIR) found illegal online pharmacies are using Twitter to promote prescription drug abuse of controlled substances.